Limitations, agreements, and source contact

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma · Source last updated 2026-04-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

DANIEL.SHERBENOU@cuanschutz.edu

organization

HCTU

phone

(303) 724-9520

title

Daniel Sherbenou

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice